Projects per year
Personal profile
Chinese Name
符秀琼
Biography
Dr. Fu is currently a Research Assistant Professor at School of Chinese Medicine. She graduated with B.Sc. and M.Sc. degree in Southern Medical University in 2009 and 2012, respectively. She obtained his Ph.D. degree in pharmaceutical Sciences in Chinese Medicine from Hong Kong Baptist University in 2017. She then received postdoctoral training at the School of Chinese Medicine of Hong Kong Baptist University from 2017 to 2020.
Research Interests
Dr. Fu's research interests are anticancer properties of Chinese medicines and novel pathogenic factors of cancers.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Xiuqiong FU is active. Topic labels come from the works of this scholar.
- 1 Similar Scholars
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Equipment Matching Fund - High-performance Slide Scanner
LIU, J., LI, F., YU, Y., XU, J., FU, X., WONG, H. L. X., KWAN, H. Y. & CHONG, W. P.
26/03/24 → 25/03/26
Project: Research project
-
靶向DNA复制起始蛋白的共同转录因子PAX2治疗癌症 Targeting PAX2, a common transcriptional regulator of DNA replication-initiation proteins, for treating cancer
YU, Z., FU, X., WANG, L., WANG, X. & WU, J.
1/01/24 → 31/12/26
Project: Research project
-
Pharmacological Studies for Developing Si-Jun-Zi-Tang Extract as an Adjuvant of Temozolomide in Treating Glioblastoma
YU, Z., FU, X., LI, S. M. A., WU, J. & WANG, X.
16/11/23 → 15/05/25
Project: Research project
-
Use of Si-Jun-Zi-Tang as an adjuvant of temozolomide for treating melanoma
1/11/22 → 30/04/25
Project: Research project
-
Ranunculi Ternati Radix inhibits STAT3 signaling through upregulating miR-351 to exert anti-melanoma effects
1/09/21 → 31/08/23
Project: Research project
Research Output
-
Activation of APE1 modulates Nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy
Diao, J., Fan, H., Zhang, J., Fu, X., Liao, R., Zhao, P., Huang, W., Huang, S., Liao, H., Yu, J., Pan, D., Wang, M., Xiao, W. & Wen, X., 20 Feb 2024, In: International Immunopharmacology. 128, 11 p., 111529.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Identification of sedative-hypnotic compounds shared by five medicinal Polyporales mushrooms using UPLC-Q-TOF-MS/MS-based untargeted metabolomics
Chen, W., Yu, J. W., Deng, Y. Y., Wong, L. Y., Wang, C., Liang, Y. L., Leung, Y. T., Tian, J. Y., Wu, Y., Leung, K. S. Y., Hu, J., Chen, W. H., Dou, X., Fu, X. Q., Chen, Y. J. & Yu, Z. L., 12 Jan 2024, In: Phytomedicine. 128, 11 p., 155355.Research output: Contribution to journal › Journal article › peer-review
-
Sea bass (Lateolabrax maculatus) exerts anti-ulcerative colitis effects through gut microbiota modulation
Chen, J., Xiao, Y., Wang, K., Fu, X., Fan, Y., Hossen, M. J., Chen, Y., Bai, W., Yu, Z. & Xu, B., Mar 2024, In: Food Frontiers. 5, 2, p. 522-534 13 p.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Shenshuai Yingyang Jiaonang ameliorates chronic kidney disease-associated muscle atrophy in rats by inhibiting ferroptosis mediated by the HIF-1α/SLC7A11 pathway
Ju, L., Diao, J., Zhang, J., Dai, F., Zhou, H., Han, Z., Hu, R., Pei, T., Wang, F., He, Z., Fu, X., Wang, M., Xiao, W. & Ma, Y., 30 Apr 2024, In: Heliyon. 10, 8, 21 p., e29093.Research output: Contribution to journal › Journal article › peer-review
Open Access -
A tri-herb formulation protects against ethanol-induced mouse liver injury and downregulates mitogen-activated protein kinase phosphatase 1
Chen, W., Deng, Y-Y., Yu, J-W., Leung, Y-T., Bai, J-X., Chen, Y-J., Wu, Y., Wang, L., Fan, X-Y., Wang, X-Q., Hu, J., Chen, W-H., Dou, X., Leung, K. S. Y., Fu, X-Q. & Yu, Z-L., Jun 2023, In: Phytomedicine. 114, 6 p., 154802.Research output: Contribution to journal › Journal article › peer-review
1 Citation (Scopus)
Prizes
-
Certificate for Excellence for an abstract presented at the 2022 World Federation of Chinese Medicine Societies Meeting
FAN, Xiaoyun (Recipient), WU, Ying (Recipient), FU, Xiuqiong (Recipient) & YU, Zhiling (Recipient), 23 Jun 2023
Prize: Award
File
Activities
-
BMC Complementary Medicine and Therapies (Journal)
Xiuqiong FU (Member of editorial board)
21 Jul 2023 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
China association of Chinese Medicine (External organisation)
Xiuqiong FU (Committee/panel/advisory board member)
13 Oct 2023 → 12 Oct 2027Activity: Membership › Membership of board/committee/council
-
Frontiers in Oncology (Journal)
Xiuqiong FU (Associate editor)
30 May 2022 → 30 May 2023Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)